Browse studies

Find your next paid study

33 recruiting studies matching your filters

Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)

This longitudinal study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and…

Carcinoma, Non-Small-Cell Lung

Estimated

~$10 – $1,125

US Oncology ResearchNCT05885698

Phase 1

Phase I Trial Evaluating the Safety of the Dietary Supplement Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer

This is a Phase I Trial evaluating the safety of the dietary supplement honokiol for lung cancer chemoprevention. Female or male patients aged 18 years, or old…

Carcinoma, Non-Small-Cell Lung

Estimated

~$10 – $6,250

The Methodist Hospital Research InstituteNCT06566443

Development and Analysis of a Sample Bank (Blood, Urine, and Stool) for Cancer Patients, Enabling the Systematic Study of the Effect of Blood, Urinary Tract, and Gut Microbiomes on Response to Treatment

This study is aimed at understanding the impact of gut microbiota on efficacy of cancer therapies, in particular checkpoint inhibitors, and using the resulting…

Carcinoma, Non-Small-Cell LungCarcinoma, Colorectal

Estimated

~$10 – $1,050

Persephone BiosciencesNCT04291755

Observational

Patient-centered, Optimal Integration of Survivorship and Palliative Care

The goal of this study is to develop and test the feasibility of a supportive care model (POISE) for patients with metastatic Non-small Cell Lung Cancer (NSCLC…

Stage IV Non-small Cell Lung CancerTargeted TherapyNonsmall Cell Lung Cancer+5 more

Estimated

~$10 – $6,250

Massachusetts General HospitalNCT04900935

Phase 2

Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase Inhibitors (The HARMONIC Study)

The goal of this clinical trial is to determine clinical advantages for LP-300 in combination with carboplatin and pemetrexed in the never smoker patient popul…

Adenocarcinoma of LungCarcinoma, Non-Small-Cell Lung

Estimated

~$10 – $8,750

Lantern Pharma Inc.NCT05456256

Phase 1

Phase 1 Trial Evaluating the Safety and Tolerability of Gamma Delta T-Cell Infusions in Combination With Low Dose Radiotherapy in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer or Solid Tumors With Bone Metastases

This is a clinical trial studying intravenous infusions of allogeneic gamma delta T cells after receiving low dose radiotherapy in participants with locally ad…

Carcinoma, Non-Small-Cell Lung CancerBone Metastases From Solid Tumors

Estimated

~$10 – $8,750

Kiromic BioPharma Inc.NCT06069570

Observational

Bronchoscopy With and Without Needle-based Confocal Laser Endomicroscopy for Peripheral Lung Nodule Diagnosis: Protocol for a Multicenter Randomized Controlled Trial (CLEVER Trial)

The goal of this multi-center randomized clinical trial is to evaluate the added value of needle based confocal laser endomicroscopy (nCLE)-imaging to regular …

Lung CancerLung Neoplasm MalignantCarcinoma, Non-Small-Cell Lung+1 more

Estimated

~$10 – $6,250

Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)NCT06079970

Phase 2

A Multicenter Phase II Randomized Trial Of Immunotherapy Versus Chemotherapy Guided By Circulating Tumor DNA-Based Molecular Response On Patients With Metastatic NSCLC

This clinical trial plans to assess to what extent the on-treatment circulating tumor DNA (ctDNA) can predict the subset of patients with NSCLC who will respon…

Carcinoma, Non-Small-Cell Lung

Estimated

~$10 – $7,500

Hackensack Meridian HealthNCT05715229

Phase 2

Multicenter Randomized Phase II Trial of Neoadjuvant Radioimmunotherapy Versus Chemoimmunotherapy in Patients With Clinical Stages IB-III (N2) Non-small Cell Lung Cancer

The goal of this clinical trial is to learn if Cemiplimab with chemotherapy or Cemiplimab with stereotactic body radiation therapy (SBRT) works as treatment fo…

Carcinoma, Non-Small-Cell Lung

Estimated

~$10 – $6,250

Weill Medical College of Cornell UniversityNCT06623656